You are here: Policies > Familial Hypercholesterolaemia (adult)
 

Familial Hypercholesterolaemia (adult) (policy currently under review)

The UK NSC policy on Familial Hypercholesterolaemia screening in adults

Policy Recommendation

Systematic population screening programme not recommended

 

This policy is currently being reviewed as part of the UK NSC's regular review cycle of all policies.

The review process began in Oct 2014 and is estimated to be completed by Jun 2015.

Type Adult
 

A national screening programme for FH is not recommended.

 
Key downloads Last external review - Expert Review for Familial Hypercholesterolaemia
 

What is screening?

More about Familial Hypercholesterolaemia (adult)

Familial hypercholesterolaemia (or hyperlipidaemias) are inherited metabolic disorders which include harmful disorders resulting in an excess of cholesterol and/or triglyceride in the blood. Cholesterol is transported round the body in combination with proteins, known as lipoproteins, low density lipoproteins (LDL) and beneficial high density lipoproteins (HDL). Triglyceride travels within very low density lipoproteins (VLDL) and chylomicrons.

» Read more about familial hypercholesterolaemia on NHS Choices

Policy stakeholders

British Heart Foundation
British Inherited Metabolic Disease Group
Genetic Alliance UK
HEART UK
Royal College of Pathologists
Royal College of Physicians
Royal College of Physicians and Surgeons of Glasgow
Royal College of Physicians of Edinburgh
Scottish Lipid Forum

The stakeholder groups will be involved when the policy is next reviewed. If you think your organisation should be added, please contact us. More about the policy review process, including the role of stakeholders, can be found in the guide to Engaging with the UK NSC's policy review process.

Related documents

icon Summary of Policy and Consultation Responses for Familial Hypercholesterolaemia (PDF document, 598KB, 15/12/11)

More options

Go to top
 
page image